glp-1 vs metformin Clinical Focus on Agonists in Type 2 Diabetes Mellitus Are GLP-1s and SGLT2s replacements
Description
Chronic co-administration of selective mono-agonists to obese non-human primates resulted in significantly more body weight loss when compared to the individual treatments, thus demonstrating the translation of these acute effects observed in humans and the chronic effects observed in primates [673]
A 2025 meta-analysis in JAMA Psychiatry found no increase in depression or suicidality with GLP-1 medications versus placebo
It has also been confirmed that AD pathologic markers, oligomeric A and A plaque load, could be reduced by LG and microglial activation is decreased and memory behaviors are improved in APP swe /PS1_E9 (APP/PS1) mouse model after using LG (74)
[DOI] [PubMed] [Google Scholar] 289.Liu, N., Wang, Y., Li, T
Dive into the role of stress management and cardiovascular health programs in preventing coronary conditions
